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 ABSTRACT 
 
Objective 
Diets with high glycemic index (GI), glycemic load (GL), or high in all carbohydrates, may 
predispose to higher blood glucose and insulin concentrations, glucose intolerance and risk of 
type 2 diabetes. We aimed to conduct a systematic literature review and dose-response meta-
analysis of evidence from prospective cohorts.  
Research Design and Methods 
We searched the Cochrane Library, MEDLINE, MEDLINE in-process, Embase, CAB 
Abstracts, ISI Web of Science and BIOSIS were searched for prospective studies of GI, GL, 
and total carbohydrates in relation to risk of type 2 diabetes, up to July 17
th
 2012. Data were 
extracted from 24 publications on 21 cohort studies. Studies using different exposure 
categories were combined on the same scale using linear and nonlinear dose-response trends. 
Summary relative risks (RR) were estimated using random-effects meta-analysis. 
Results 
The summary RR was 1.08 per 5 GI units (95% confidence interval [CI]: 1.02 – 1.15, 
p=0.01), 1.03 per 20 GL units (95% CI: 1.00 – 1.05, p=0.02), and 0.97 per 50 g/day of 
carbohydrate (95% CI: 0.90 – 1.06, p=0.5). Dose-response trends were linear for GI and GL, 
but more complex for total carbohydrate intake. Heterogeneity was high for all exposures 
(I
2
>50%), partly accounted for by different covariate adjustment and length of follow-up.  
Conclusions 
Included studies were observational, so should be interpreted cautiously. However, our 
findings are consistent with protective effects of low dietary GI and GL, quantifying the 
range of intakes associated with lower risk. Future research could focus on the type of sugars 
and other carbohydrates associated with greatest risk. 
 
 
 INTRODUCTION 
Type 2 diabetes is a leading cause of cardiovascular disease, with a global prevalence of 10% 
(1). An individual’s diet is considered to contribute to the development of type 2 diabetes, in 
particular, the capacity that foods containing carbohydrates have to increase blood glucose 
(2). It has been suggested that diets with high Glycemic Index (GI) or Glycemic Load (GL) 
may predispose to higher postprandial blood glucose and insulin concentrations, which in 
turn increase glucose intolerance and risk of eventual type 2 diabetes (3). 
 
A number of studies have indicated an association between GI, GL and type 2 diabetes(4-8), 
but there are many other large studies that find no evidence to support the hypothesis (9-11). 
Accordingly, the American Diabetes Association’s dietary guidelines for diabetes prevention 
currently state that there is insufficient consistent evidence to say that diets low in GL reduce 
diabetes risk (12). There is also considerable inconsistency in results regarding the role of 
total carbohydrate intake. 
 
Two systematic reviews have concluded that there is evidence of a positive association 
between both dietary GI and GL and risk of type 2 diabetes(13,14), but with considerable 
unexplored heterogeneity. The comparison of only the most extreme categories, based on 
different definitions in each reviewed study, introduced additional heterogeneity and 
discarded information in the middle exposure categories, leading to uncertainty regarding the 
strength of the association. Combination of different definitions of the highest and lowest 
exposure categories meant that their summary estimates could not be related to a particular 
level of exposure, limiting the applicability of results in public health terms. Furthermore, the 
review did not assess the nature of any dose-response relationship, an important criteria for 
judging the chances of any associations being causal. 
 
Results from 9 publications from 8 large prospective studies have been published since the 
most recent review, including almost 20000 cases of type 2 diabetes from over 250000 
participants. We therefore assess the evidence accumulated to date, investigating possible 
dose-response curves, and formally exploring the potential causes of heterogeneity that may 
lead to deeper understanding of the nature of the associations. 
 
METHODS 
Data sources and searches 
A comprehensive systematic literature search was conducted at the end of 2009 covering all 
prospective research providing evidence on all aspects of dietary carbohydrates and cardio-
metabolic health, including cardiovascular disease, insulin resistance, glycemic response and 
obesity. The following online databases were searched for all prospective studies published in 
English language from 1st January 1990 to 30
th
 November 2009: The Cochrane Library, 
MEDLINE, MEDLINE in-process, Embase, CAB Abstracts, ISI Web of Science and 
BIOSIS. We then updated the search, using the two primary sources (Medline, including 
Medline in-process, and Embase) up to 17
th
 July 2012. The updated search was restricted to 
cohort studies investigating GI, GL, total carbohydrate intake and type 2 diabetes (detailed 
search strategy in supplementary table 1). Hand searches of key journals, with searching of 
reference lists from included studies and previous review articles, were also conducted. The 
guidelines for conducting meta-analysis of observational studies in epidemiology were used 
throughout the design, conduct, analysis, and reporting of this review (15). A protocol was 
drafted prior to starting the review 
(http://www.sacn.gov.uk/meetings/working_groups/carbohydrate/21092009_1.html) but is 
not currently available for download. 
 
Study selection 
The first round of screening of titles and abstracts was carried out by members of the review 
team to remove publications it was immediately apparent were not relevant, such as 
editorials, single case-study reports and therapeutic approach articles. Pre-specified 
guidelines were in place to ensure consistency between separate reviewers. We extracted full-
text copies of potentially relevant articles, which were read independently by two members of 
the review team. Any disagreements were settled by a third reviewer. A structured flow chart 
and detailed guidelines were used to determine eligibility for inclusion. 
 
Only cohort studies were eligible, including nested case-control studies and case-cohort 
studies nested within a cohort. Inclusion criteria were: studies based on an adult population, 
published in the English language since 1990, with assessment of GI, GL or total dietary 
carbohydrate intake with more than two categories of exposure, with at least some control for 
confounding either by adjustment in a model or matching, type 2 diabetes as an outcome, and 
some estimate of relative risk with a measure of uncertainty such as 95% confidence 
intervals. Only studies with generally healthy participants were included, i.e. only if cohort 
participants were not recruited specifically because of ill health or a personal history of 
disease. Mean dietary exposure for cases compared to non-cases were not eligible unless they 
were adjusted means. Results for dietary patterns were not eligible if they did not quantify 
intake. Gestational diabetes outcomes were not eligible. Study selection was carried out by 
two researchers from DCG, DET, CELE, CLC, CN, and VJB, with disagreements resolved 
by a third researcher. 
 
For inclusion in dose-response meta-analysis, only studies publishing estimates of relative 
risk with associated confidence intervals, alongside a quantified measure of intake, and 
sufficient detail regarding the numbers of cases and non-cases or person-years exposure could 
be included. 
 
Data extraction and quality assessment 
We extracted the following information from the publications identified: authors, publication 
year, geographical region of the study, name by which the study is known, participants’ 
gender, age range or mean age of participants, study type (full cohort, nested case-control, or 
case-cohort), length of follow-up, numbers of cases and non-cases, method of dietary 
assessment, and method of outcome assessment, level of dietary exposure (either as mean, 
median, midpoint or range for each category or unit of increment for continuous estimates), 
the standard used to derive GI or GL (glucose or bread) estimated relative risks with 
confidence intervals, and characteristics controlled for either by modelling, matching or 
stratification. Data extraction was carried out by DCG, DET, CELE, CLC, CN, CW, and VJB 
and its accuracy checked by DET and DCG.  
 
Data synthesis and analysis 
To enable pooling of individual study results reported using different exposure categorisation, 
a linear dose-response trend was derived for each study using Greenland and Longnecker’s 
method (16,17). This method estimates study-specific dose-response slopes and associated 
confidence intervals, based on the results presented for each category of GI, GL or total 
dietary carbohydrate intake before combining into a pooled estimate. 
 
To derive the dose-response trend, we used the mean or median exposure for each category if 
this was presented and used the midpoint when exposure ranges were presented instead. 
When the lowest or highest categories were unbounded, we assumed the width of the 
category to be the same as the adjacent category when estimating the midpoint. Greenland 
and Longnecker’s method also requires the distribution of cases and person-years, or cases 
and non-cases, with relative risks and estimates of uncertainty (e.g. confidence interval) for at 
least three categories of quantified GI, GL or carbohydrate intake. Where the total number of 
cases or person-years was presented in the publication, but not the distribution, we estimated 
this based on definitions of the quantiles. The estimated exposure level (based on median, 
mean or midpoint) was then assigned to the corresponding relative risk for each study. For 
studies presenting the exposure per given unit of energy intake, we rescaled this using 
estimated energy intake for each category if this was presented. 
 
For the studies already reporting a linear dose-response trend, with a measure of precision 
such as a confidence interval or a standard error, this was used directly. Where results were 
only presented separately for men and women, these were first combined using a fixed effects 
meta-analysis before combining with other studies. This ensured that between-study 
heterogeneity was not under-estimated. All the estimated dose-response trends for each study 
were then pooled using a random effects model to take into account anticipated between-
study heterogeneity (18). In presenting the linear dose-response trend we chose an increment 
size approximately equivalent to one standard deviation in a European or US population, to 
ease comparison across exposures. 
 
To examine possible nonlinear associations, we calculated restricted cubic splines for each 
study with more than three categories of exposure, using three fixed knots at 10%, 50% and 
90% through the total distribution of reported intake, then combined using multivariate meta-
analysis (19-22). Four studies only presented results for a linear trend over a continuous 
exposure (8,10,23,24), and two studies only presented results for three categories (25,26), so 
could not be included in nonlinear dose-response analyses. 
 
We assessed between-study heterogeneity using Cochran’s Q and the percentage of total 
variation in study estimates attributable to between-study heterogeneity (I
2
) (27). Rather than 
assess study quality using a quality score, to minimise bias from confounding we excluded 
results with no adjustment for any confounding, or where only unadjusted dose-response 
trends could only be estimated. We also tabulated the following markers of risk of bias: 
adequacy of the dietary assessment tool, objectivity of ascertainment of the outcome, 
adequacy of length of follow-up, adequacy of control for confounding, and potential 
competing interests. In addition we investigated the extent to which specific study 
characteristics defined in advance, were associated with different higher or lower estimates, 
or how they potentially explained some of the heterogeneity. These characteristics included 
duration of follow-up and adjustment for pre-specified confounders, which are potential 
indicators of study quality. Potential small study effects, such as publication bias, were 
investigated with contour-enhanced funnel plots. However, with small numbers of included 
studies, exploration of sources of heterogeneity and of small study effects lack power. All 
analyses were conducted using Stata version 12 (28). 
 
RESULTS 
We identified 24 publications from 21 cohort studies that reported GI, GL, total or 
carbohydrate intake and incidence of type 2 diabetes (supplemental figure 1). One publication 
could not be used in meta-analyses because they did not quantify intake (7), one could not be 
used because they only presented results for the highest and lowest categories (29), and one 
could not be used because of the form the results were presented in the paper (30). The 
remaining 18 cohorts provided sufficient information for inclusion in dose-response meta-
analyses (supplementary table 2). The risk of bias assessment is provided in supplementary 
table 3. 
 
Nine studies were from the US, 4 from Europe, and the remainder from Australia, Japan and 
China. One cohort presented results in 3 publications (4,31,32), so we used the data in the 
most recent publication (32). A further study reported GI and load in a separate paper from 
total carbohydrate intake (11,33). For one study to be included, we estimated standard errors 
using the reported p-value and estimates (25). For another to be included, category means 
were estimated based on an assumed normal distribution with approximate mean and 
standard deviation derived from the publication (34). The exclusion of studies reporting 
unadjusted estimates had resulted in the loss of two studies presenting results for total 
carbohydrate intake that would otherwise have been included (35,36). 
 
Glycemic index 
Data were extracted from 15 publications investigating the association between GI and type 2 
diabetes (5,6,8-11,23-26,32,37-40) (figure 1a). The estimated category mean intakes ranged 
from approximately 45 to 90 units of GI, with individual studies spanning between 6 and 36 
units. The pooled estimate of relative risk from linear dose-response meta-analysis was 1.08 
(95% CI: 1.02 to 1.15) per 5 units of GI (p=0.01). There was substantial heterogeneity 
between the cohort studies (I
2
=87%, 95% CI: 80% to 92%, Q=108, df=14, p<0.001).  
 
Studies adjusting for family history of type 2 diabetes appeared to have much higher 
estimates than those not adjusting (p<0.001). The stronger association between GI and 
diabetes was restricted to those studies that adjusted for this, leading to improved 
heterogeneity within each subgroup (supplementary table 4). Estimates were largely 
consistent across the other pre-defined subgroups. The funnel plot was approximately 
symmetric, with little evidence of small-study effects such as publication bias (data not 
shown).  
Nonlinear dose-response meta-analysis showed a consistently increasing risk associated with 
increased GI (figure 1c). There was little evidence of a threshold effect in the plot. 
 
Glycemic load 
Data were extracted from 16 publications investigating the association between GL and type 
2 diabetes (5,6,8-11,23,25,26,32,34,37-41) (figure 1b). The estimated category mean intakes 
ranged from approximately 55 to 245 units of GL, with individual studies spanning between 
48 and 190 units. The pooled estimate of relative risk from linear dose-response meta-
analysis was 1.03 (95% CI: 1.00 to 1.05) per 20 units of GL (p=0.02). There was moderate 
heterogeneity between the cohort studies (I
2
=54%, 95% CI: 19% to 74%, Q=33, df=15, 
p=0.005).  
 
As with GI, studies that adjusted for family history had higher estimates than those that did 
not adjust for this covariate (p=0.03), with stronger associations between GL and diabetes 
apparent in those studies that did adjust for family history. Stratifying by family history 
improved heterogeneity within each subgroup (supplementary table 4). Longer follow-up was 
associated with stronger associations between GL and type 2 diabetes (p=0.03). Estimates 
were largely consistent across the other pre-defined subgroups. The funnel plot was 
approximately symmetric, with little evidence of small-study effects such as publication bias 
(data not shown).  
 
Nonlinear dose-response meta-analysis showed a consistently increasing risk associated with 
increased GL (figure 1d). There was little evidence of a threshold effect in the plot. 
 
Total carbohydrate 
Data were extracted from 8 studies investigating total carbohydrate intake and type 2 diabetes 
(5,8,9,23,24,32,33,42) (figure 1c). The estimated category mean intakes ranged from 
approximately 130 to 340 grams, with individual studies spanning between 72 and 210 
grams. The pooled estimate of relative risk from linear dose-response meta-analysis was 0.97 
(95% CI: 0.90 to 1.06) per 50 grams per day of total dietary carbohydrate intake (p=0.5). 
There was substantial heterogeneity between the cohort studies (I
2
=75%, 95% CI: 50% to 
88%, Q=28, df=7, p<0.001). 
 
Estimates were largely consistent across pre-defined subgroups, though there was a tendency 
for studies with longer follow-up to have larger estimates (supplementary table 4). The funnel 
plot was approximately symmetric, with little evidence of small-study effects such as 
publication bias (data not shown). 
 
Nonlinear dose-response meta-analysis showed a relatively flat curve over a broad range of 
typical intakes, with a suggestion of lower risks associated with higher intakes where data are 
more sparse and confidence intervals wider (figure 1f) and where studies had higher 
proportions of male participants. 
 
DISCUSSION 
We have quantified a clear positive association between both GI and GL with increasing 
incidence of type 2 diabetes. The association was stronger for GI than GL, with 
approximately one standard deviation of GI intake associated with more than twice the 
increased risk associated with GL. Compared to the data on dietary GI, the evidence base for 
GL is more inconsistent in terms of direction of association.  
 
Despite use of linear dose-response trends to combine studies using different exposure 
categorisations, heterogeneity was still high for all exposures. Exploration of this 
heterogeneity by investigating the estimates in different pre-defined subgroups suggested that 
adjustment for family history of diabetes was potentially important, with studies that did not 
adjust for it having much lower estimates for the association between GI, GL and type 2 
diabetes. 
 
Whilst these findings are consistent with those of two previous systematic reviews (13,14), 
our review is the first to quantify the strength of the association, the first to explore some of 
the heterogeneity in results, the first to remove some of this heterogeneity by combining 
dose-response trends, and the first to investigate possible nonlinear associations. We have 
included results from 9 publications from large prospective studies that have been published 
since the most recent review, and these include almost 20000 more cases of type 2 diabetes 
from over 250000 more participants, further strengthening the evidence on which our 
conclusions are based. 
 
Meta-analysis of observational studies is susceptible to the same biases that the studies they 
contain are prone to, so the pooled estimate may still contain an element of bias to the extent 
that the studies reviewed are biased. In particular, all the studies reviewed used some form of 
self-reported dietary exposure and therefore susceptible to potentially large measurement 
error. In addition, many adjusted for self-reported dietary covariates, so may not have fully 
adjusted for true intake. This could bias the associations in either direction. Furthermore, we 
cannot conclusively prove that any associations are causal on the basis of observational 
studies alone, and there may be some uncorrected confounding in some or all of the studies. 
However, the estimates we have found for GI and GL are strong with clear dose-response 
trends, and there was no evidence of any small-study effects such as publication bias. 
 
Given the limited nature of databases of GI values for foods, assigning a GI to an individual’s 
diet as captured by a FFQ is potentially problematic. Typically, GI values for each food item 
in a questionnaire were taken from the 2002 international table of GI values of foods (43). 
Broad groupings of foods within each FFQ item sometimes necessitates the allocation of an 
average GI for that item, and this has led some to express concerns about the appropriateness 
of using FFQ-derived GI and GL values to explore disease associations (44). The dietary GI 
of a food is subject to considerable variation dependent upon the extent of processing, 
cooking method and duration, extent of starch gelatinisation, ripeness and storage duration 
(45). Further issues concern whether foods consumed together impact on each other to alter 
the GI of the whole meal (46).  This exposure is therefore potentially prone to measurement 
error bias. The estimation of GL requires the additional estimate of the amount of 
carbohydrate in the diet, providing greater scope for dilution of results through measurement 
error bias.  
 
Even though the estimated absolute values of GI and GL are probably not accurate estimates 
of actual values in many studies, we have still used them so that the different studies can be 
combined on the same scale, and dose-response trends and nonlinear trends can be estimated. 
However, in interpreting these the emphasis should be on the relative ranking as much as on 
the estimated GI and GL. 
 
A wide range of exposures were reported across the publications, though the intakes reported 
by individual studies generally varied by smaller amounts. This may reflect the variety of 
dietary assessment tools leading to different amounts of measurement error in each study, or 
may be because of contrasting populations, different diets and phenotypes. 
 
In general the GL of a diet is likely to be partly related to the dietary fibre content, and this 
means that it is difficult to dissociate the effects of GL from the fibre content. In the studies 
we reviewed, adjustment for fibre tended to be associated with larger estimates where this 
was done (5,6,9), suggesting that other studies may have underestimated the association, and 
our pooled estimate may be an underestimate. Similarly, GI and GL may reflect other aspects 
of dietary quality, such as saturated fat intake, with findings partly reflecting some other 
dietary characteristics. It is quite likely that higher carbohydrate intakes may substitute for fat 
or protein, whilst maintaining a constant energy intake. This is another example where 
observational studies are unable to assign causality, and it is the same with their meta-
analysis. 
 
Inconsistencies in results for total carbohydrate intake and type 2 diabetes may be due to 
differences in the main sources and types of carbohydrate consumed or other differences in 
dietary practices between European, US, Chinese and Australian cohorts. It might also reflect 
the possibility that healthier, more active people are consuming more carbohydrate. An 
alternative explanation may relate to differences between both the amount of carbohydrate 
consumed and the type of carbohydrate eaten, with different cohorts also having different 
proportions of men and women.  
 
This may also account for any nonlinear appearance of the dose-response plot, with studies 
reporting higher intakes of total carbohydrates having different sources of carbohydrate in the 
diet than those reporting lower intakes. Nonlinear dose-response curves are susceptible to 
cohorts with different ranges of intake leading to the appearance of a nonlinear curve. In this 
situation, differences in design or population can cause the appearance of nonlinearity. 
However, there is a reasonable spread of carbohydrate intakes over a number of studies 
included in the meta-analysis, so this is unlikely to have occurred in this review. 
 
Our findings are consistent with, and contribute to, a growing body of evidence for the 
protective associations with low dietary GI and GL. Our results have quantified for the first 
time the range of exposures associated with lower risk, and quantified the risk reduction 
associated with specified differences in GI and GL. Results for carbohydrates more generally 
are less clear, and future research could focus in more detail on the source and composition of 
carbohydrates associated with greatest risk. 
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 Figure legend 
 
Figure 1. Glycemic Index, glycemic load, total carbohydrate intake and estimated relative risk of type 
2 diabetes. Forest plots of linear dose-response trends with pooled estimates from random effects 
meta-analysis (A to C). Increments used are approximately one standard deviation. Summary 
nonlinear dose-response curves (D to F). The median intake is used as the reference category. Tick 
marks on the horizontal axis indicate the location of category medians, means or midpoints for 
included studies. 
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Supplemental table 1. Search strategies. 
Medline 
 
1. exp cohort studies/ 
2. cohort$.tw. 
3. epidemiologic methods/ 
4. or/1-3 
5. (animals not (humans and animals)).sh. 
6. 4 not 5 
7. exp dietary carbohydrates/ 
8. carbohydrat$.ab,ti. 
9. ((glucose or fructose or lactose or maltose or sucrose) adj3 (diet$ or intake$)).tw. 
10. sugar$.ab,ti. 
11. sucrose/ 
12. monosaccharide$.tw. 
13. disaccharide$.tw. 
14. isomaltose/ 
15. maltose/ 
16. glycemic index/ 
17. ((index or load) adj3 glyc?emic).tw. 
18. ((diet$ or low or high) adj3 GI).tw. 
19. ((diet$ or low or high) adj3 GL).tw. 
20. or/7-19 
21. Diabetes Mellitus, Type 2/ 
22. (type 2 adj3 diabetes).tw. 
23. (type II adj3 diabetes).tw. 
24. (inciden$ adj3 diabetes).tw. 
25. or/21-24 
26. 6 and 20 and 24 
27. limit 26 to english language 
28. limit 27 to yr="2009 -Current" 
 
 Embase 
 
1. exp Cohort Studies/ 
2. epidemiology/ 
3. cohort$.tw. 
4. exp carbohydrate diet/ 
5. exp carbohydrate intake/ 
6. exp carbohydrate intake/ 
7. carbohydrat$.tw. 
8. ((glucose or fructose or lactose or maltose or sucrose) adj3 (diet$ or intake$)).tw. 
9. sugar$.tw. 
10. sucrose/ 
11. monosaccharide$.tw. 
12. disaccharide$.tw. 
13. isomaltose/ 
14. maltose/ 
15. glycemic index/ 
16. glycemic load/ 
17. ((index or load) adj3 glyc?emic).tw. 
18. ((diet$ or low or high) adj3 GI).tw. 
19. ((diet$ or low or high) adj3 GL).tw. 
20. non insulin dependent diabetes mellitus/ 
21. or/1-3 
22. or/4-19 
23. 21 and 22 and 20 
24. limit 23 to english language 
25. limit 24 to yr="2009 -Current" 
 
 
 
 Supplemental figure 1. Article retrieval and screening process for original SACN literature search (all carbohydrates and cardio-metabolic diseases) and 
update search (incident type 2 diabetes and GI, GL, or total dietary carbohydrate intake. 

  
Supplemental table 2. Characteristics of studies included in meta-analyses of glycemic index, glycemic load, or carbohydrate intake and incidence of type 2 
diabetes. 
Author, year, region Study name Participant 
characteristics 
Follow-up Case/total Exposure 
ascertainment 
Outcome ascertainment Exposures 
Barclay et al., 2007, 
Australia (24)  
Blue Mountains Study Age 49+, mean age 
65, 44% male 
10 years 138/3654 FFQ (145 item) Self-report and current 
medication, or fasting 
glucose ≥126 mg/dl 
GI, total 
carbohydrate 
Hodge et al, 2004, 
Australia (23)  
Melbourne 
Collaborative Cohort 
Study 
Age 27-75, mean age 
54, 41% male, multi-
ethnic 
4 years 365/41528 FFQ (121 items) Fasting blood glucose GI, GL, total 
carbohydrate 
Hopping et al, 2010, 
USA (34)  
Multiethnic Cohort 
Hawaii 
Age 45-75, 48% 
male 
14 years 8587/75512 FFQ (178 items) Confirmed self-report GL 
Krishnan et al, 2007, 
USA (6) 
Black Women’s Health 
Study 
Age 21-69, 0% male, 
black 
8 years 1938/40078 FFQ (68 items) Self-reported GI, GL 
Meyer et al, 2000, 
USA (9) 
Iowa Women’s Health 
Study 
Age 55-69, mean age 
61, 0% male 
6 years 1141/35988 FFQ (127 items) Self-reported GI, GL, total 
carbohydrate 
Mosdol et al, 2007, UK 
(38) 
Whitehall II Study Mean age 50, 71% 
male 
13 years 329/7321 FFQ (127 items) Glucose tolerance test GI, GL 
Sahyoun et al, 2008, 
USA (39) 
Health, Ageing, and 
Body Composition 
Mean age 75, 46% 
male, multi-ethnic 
6 years 99/1898 FFQ (108 items) Multiple methods GI, GL 
Study 
Sakurai et al, 2012, 
Japan (40) 
 Age 35-55, 100% 
male, factory 
workers 
6 years 133/7604 FFQ (147 items) Confirmed self-report GI, GL 
Salmeron et al, 1997a, 
USA (4) 
Health Professionals 
Follow-up Study 
Age 40-75, 100% 
male 
6 years 523/42759 FFQ (131 items) Confirmed self-report GI, GL, total 
carbohydrate 
Salmeron et al, 1997b 
(5), Halton et al, 2008 
(31), Mekary et al, 
2011, USA (32) 
Nurses’ Health Study Age 40-65, 0% male 26 years 6950/81827 FFQ (134 items) Confirmed self-report GI, GL, total 
carbohydrate 
Schulz et al, 2006, 
USA (25) 
Insulin Resistance 
Atherosclerosis Study 
Age 40-69, mean age 
55, 46% male, multi-
ethnic 
5 years 146/892 FFQ (114 items) Glucose tolerance test GI, GL 
Schulze et al, 2004, 
USA (37) 
Nurses’ Health Study II Age 25-44, 0% male 8 years 741/91249 FFQ (133 items) Confirmed self-report GI, GL 
Schulze et al, 2008, 
Germany (42) 
EPIC Potsdam Age 35-65, 40% 
male 
7 years 846/27548 FFQ (148 items) Confirmed self-report Total 
carbohydrate 
Simila et al, 2011 (11), 
Simila et al, 2012, 
Finland (33) 
Alpha-tocopherol, 
Beta-carotene Cancer 
Prevention Study 
Age 50-69, 100% 
male, smokers 
12 years 1098/25943 FFQ (276 items) Confirmed self-report GI, GL, total 
carbohydrate 
Sluijs et al, 2010, The 
Netherlands (8) 
EPIC Netherlands Mean age 51, 26% 
male 
10 years 915/37846 FFQ (178 items) Confirmed self-report GI, GL, total 
carbohydrate 
Stevens et al, 2002, 
USA (10) 
Atherosclerosis Risk in 
Communities (ARIC) 
study 
Age 45-64, mean age 
54, 44% male, multi-
ethnic 
9 years 1447/15792 FFQ (66 items) Fasting glucose ≥126 
mg/dl or non-fasting 
glucose ≥200 mg/dl 
GI, GL 
van Woudenbergh et 
al, 2011, The 
Netherlands (26) 
The Rotterdam Study Age >55, mean age 
67, 40% male 
12-15 
years 
456/4366 FFQ (170 items) Plasma glucose 
≥7.0mmol/L, random 
plasma glucose  
≥11.1 mmol/L, diabetes 
medication, or diet  
GI, GL 
Yu et al, 2011, China 
(41) 
Hong Kong Dietary 
Survey 
Age 25-74, 48% 
male 
12 years 74/690 FFQ (266 items) Confirmed self-report GL 
 
 Supplemental table 3. Risk of bias assessment for PRISMA checklist. 
Author, year, region Study name Adequate dietary 
assessment tool * 
Objective 
outcome 
ascertainment † 
Adequate 
follow-up ‡ 
Adequate 
adjustment for 
confounding § 
Potential 
competing 
interest || 
Barclay et al., 2007 (24)  Blue Mountains Study Y Y Y N Y 
Hodge et al, 2004 (23)  Melbourne 
Collaborative Cohort 
Study 
Y Y N Y N 
Hopping et al, 2010 (34)  Multiethnic Cohort 
Hawaii 
Y Y Y Y N 
Krishnan et al, 2007 (6) Black Women’s 
Health Study 
N N N Y N 
Meyer et al, 2000 (9) Iowa Women’s Health 
Study 
Y N N Y N 
Mosdol et al, 2007 (38) Whitehall II Study Y Y Y Y N 
Sahyoun et al, 2008 (39) Health, Ageing, and 
Body Composition 
Study 
Y Y N Y N 
Sakurai et al, 2012 (40) Toyama factory 
workers cohort 
Y Y Y N N 
Salmeron et al, 1997a, (4) Health Professionals 
Follow-up Study 
Y Y N Y N 
Salmeron et al, 1997b (5),  
Halton et al, 2008 (31),  
Mekary et al, 2011 (32) 
Nurses’ Health Study Y Y Y Y N 
Schulz et al, 2006 (25) Insulin Resistance 
Atherosclerosis Study 
Y Y N N N 
Schulze et al, 2004 (37) Nurses’ Health Study 
II 
Y Y N Y N 
Schulze et al, 2008 (42) EPIC Potsdam Y Y N N N 
Simila et al, 2011 (11),  
Simila et al, 2012 (33) 
Alpha-tocopherol, 
Beta-carotene Cancer 
Prevention Study 
Y Y Y Y N 
Sluijs et al, 2010 (8) EPIC Netherlands Y Y Y Y N 
Stevens et al, 2002  (10) Atherosclerosis Risk 
in Communities 
(ARIC) study 
N Y N Y N 
van Woudenbergh et al, 2011 (26) The Rotterdam Study Y Y Y Y N 
Yu et al, 2011 (41) Hong Kong Dietary 
Survey 
Y Y Y Y N 
* Adequate dietary assessment was considered to be a measure that was validated, and covering at least 100 separate food items for precision. 
† Objective outcome assessment was considered to be fasting glucose, fasting or non-fasting glucose, medical records, or self-report confirmed by one of 
these objective methods. 
‡ Adequate follow-up was considered to be 10 years or more. 
§ Adequate adjustment for confounding was considered to be adjustment for age, gender and anthropometric measures. 
|| We interpreted potential competing interests in the broadest sense, according to information presented in the publication. 
*, †, ‡, §, ||, ¶, #, **, ††, ‡‡ 
 
 Supplementary table 4. Subgroup analyses for glycemic index, glycemic load, total carbohydrate intake and incidence of type 2 diabetes.  
  Glycemic Index (per 5 units/day)  Glycemic load (per 20 units/day)  Total Carbohydrate (per 50g/day) 
Subgroup  RR (95% CI) I2 n Phet 
a Phet 
b  RR (95% CI) I2 n Phet 
a Phet 
b  RR (95% CI) I2 n Phet 
a Phet 
b 
Subjects' gender Male 1.07 (0.93, 1.24) 74% 3 .02 .7  1.02 (1.00, 1.05) 14% 4 .3 .6  0.90 (0.84, 0.96) 0% 3 .8 .3 
 Mixed 1.05 (0.99, 1.12) 42% 8 .1   1.02 (0.97, 1.07) 51% 8 .05   1.04 (0.81, 1.33) 76% 3 .02  
 Female 1.12 (0.99, 1.26) 97% 4 <0.001   1.05 (1.01, 1.09) 45% 4 .1   1.03 (0.95, 1.12) 51% 3 .1  
Standard used to derive GI 
values 
Glucose 1.09 (1.04, 1.13) 0% 4 .7   1.07 (0.99, 1.15) 76% 4 .005        
White bread 0.99 (0.94, 1.04)  1    1.01 (0.97, 1.04)  1         
Not stated 1.08 (0.98, 1.18) 91% 10 <0.001 .6  1.02 (0.98, 1.05) 41% 11 .08 .4       
Length of follow-up <10 years 1.08 (1.02, 1.14) 80% 9 <0.001   1.02 (0.99, 1.04) 0% 9 .5   0.93 (0.88, 0.98) 0% 4 .4  
 ≥10 years 1.07 (0.95, 1.20) 85% 6 <0.001 .5  1.04 (0.99, 1.08) 75% 7 <0.001 .03  1.05 (0.89, 1.22) 82% 4 <0.001 .1 
Geographic location Americas 1.09 (1.00, 1.18) 93% 8 <0.001   1.03 (1.01, 1.06) 50% 9 .04   1.02 (0.93, 1.11) 64% 3 .06  
 EU 1.00 (0.92, 1.09) 41% 4 .2   1.03 (0.89, 1.19) 79% 4 0.002   0.96 (0.83, 1.13) 76% 3 .02  
 Other 1.18 (1.07, 1.30) 0% 3 .7 .3  0.99 (0.94, 1.05) 0% 3 .7 .2  0.92 (0.79, 1.07) 33% 2 .2 .2 
Adjusted for age Yes 1.08 (1.02, 1.15) 87% 15 <0.001   1.03 (1.00, 1.05) 54% 16 .005   0.97 (0.90, 1.06) 75% 8 <0.001  
 No   0      0      0   
Adjusted for alcohol Yes 1.08 (0.99, 1.17) 90% 11 <0.001   1.03 (0.99, 1.07) 57% 12 .008   0.99 (0.90, 1.08) 77% 6 <0.001  
 No 1.06 (0.98, 1.14) 65% 4 .03 .9  1.02 (1.01, 1.04) 10% 4 .3 .9  0.92 (0.80, 1.05) 33% 2 .2 .6 
Adjusted for anthropometry Yes 1.07 (1.01, 1.14) 88% 14 <0.001   1.03 (1.00, 1.05) 54% 16 .005   0.97 (0.89, 1.06) 78% 7 <0.001  
No 1.22 (0.98, 1.54)  1  .4    0    1.03 (0.81, 1.32)  1  .7 
Adjusted for energy intake Yes 1.09 (1.02, 1.17) 89% 12 <0.001   1.03 (1.00, 1.06) 64% 12 0.001   0.98 (0.88, 1.08) 82% 6 <0.001  
No 1.03 (0.94, 1.12) 51% 3 .1 .4  1.02 (0.99, 1.04) 0% 4 .8 .9  0.96 (0.85, 1.08) 0% 2 .5 1 
Adjusted for family history Yes 1.14 (1.08, 1.21) 67% 9 .002   1.05 (1.02, 1.09) 43% 9 .08   1.02 (0.90, 1.15) 75% 5 .003  
No 0.98 (0.96, 1.00) 0% 6 .7 <0.001  1.01 (1.00, 1.03) 9% 7 .4 .03  0.92 (0.86, 0.99) 34% 3 .2 .3 
Adjusted for physical 
activity 
Yes 1.08 (1.02, 1.15) 89% 13 <0.001   1.03 (1.01, 1.06) 59% 14 .003   0.97 (0.90, 1.06) 75% 8 <0.001  
No 1.04 (0.89, 1.22) 30% 2 .2 .7  0.98 (0.88, 1.08) 0% 2 .8 .4    0   
Adjusted for gender Yes 1.08 (1.01, 1.15) 88% 14 <0.001   1.03 (1.01, 1.05) 54% 15 .004   0.99 (0.90, 1.08) 76% 7 <0.001  
 No 1.12 (0.94, 1.34)  1  .7  0.96 (0.84, 1.10)  1  .5  0.91 (0.83, 1.00)  1  .5 
Adjusted for smoking Yes 1.07 (1.01, 1.14) 88% 13 <0.001   1.03 (1.01, 1.06) 54% 15 .006   1.01 (0.93, 1.11) 68% 6 .007  
 No 1.15 (1.02, 1.29)  1  .5  0.97 (0.89, 1.05)  1  .3  0.88 (0.81, 0.94) 0% 2 .9 .1 
a
 P for heterogeneity within each subgroup.   
b
 P for heterogeneity between each subgroup 
 
 
 
 
